Prognostic Value of Cyclooxygenase-2 Expression in Squamous Cell Carcinoma of the Bladder
- 21 January 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 185 (3) , 1112-1117
Abstract
Inflammation is associated with the pathogenesis of carcinoma, including squamous cell carcinoma of the bladder. Cyclooxygenase-2 is an enzyme that is induced at inflammation sites. We assessed the expression pattern of cyclooxygenase-2 in patients with squamous cell carcinoma of the bladder and determined whether cyclooxygenase-2 expression is associated with clinical outcomes after radical cystectomy. Immunohistochemical staining for cyclooxygenase-2 was done on archival bladder specimens from 152 patients treated with radical cystectomy for squamous cell carcinoma on the Autostainer (DakoCytomation, Carpinteria, California). Bright field microscopy imaging coupled with advanced color detection software was used. Cyclooxygenase-2 was defined as over expressed when greater than 20% cells were positive. We assessed the relationship of cyclooxygenase-2 expression with pathological parameters and clinical outcome. The study included 99 male and 53 female patients with a mean age of 52 years who had squamous cell carcinoma, including 80.9% with bilharziasis. Presenting stage was T2 or greater and presenting grade was GII or less in 93.4% of patients. Median followup was 63.2 months. Cyclooxygenase-2 was over expressed in 74 cystectomy specimens (48.7%) and associated with higher pathological stage (p = 0.003) and grade (p = 0.049). On multivariate Cox proportional hazards regression analysis cyclooxygenase-2 over expression was associated with disease recurrence (p = 0.031) and bladder cancer specific mortality (p = 0.046). Cyclooxygenase-2 over expression is associated with pathological stage, grade and worse outcomes after radical cystectomy, suggesting a role in bladder squamous cell carcinoma progression. Our findings support the need for further evaluation of cyclooxygenase-2 and inflammatory signaling pathways, and cyclooxygenase-2 targeted prevention or therapy in patients with bladder squamous cell carcinoma.Keywords
This publication has 25 references indexed in Scilit:
- Incidence analyses of bladder cancer in the Nile delta region of EgyptCancer Epidemiology, 2009
- Cyclooxygenase‐2 expression on urothelial and inflammatory cells of cystoscopic biopsies and urine cytology as a possible predictive marker for bladder carcinomaAPMIS, 2009
- The global burden of urinary bladder cancerScandinavian Journal of Urology and Nephrology, 2008
- The cyclooxygenase‐2‐mediated prostaglandin signaling is causally related to epithelial carcinogenesisMolecular Carcinogenesis, 2007
- Chronic inflammation and bladder cancerUrologic Oncology: Seminars and Original Investigations, 2007
- Polymorphisms in Inflammation Genes and Bladder Cancer: From Initiation to Recurrence, Progression, and SurvivalJournal of Clinical Oncology, 2005
- Squamous cell carcinoma of the bilharzial and non-bilharzial urinary bladder: a review of etiological features, natural history, and managementInternational Journal of Clinical Oncology, 2005
- Squamous cell carcinoma of the bladder: pathology, diagnosis and treatmentBJU International, 2003
- Many actions of cyclooxygenase‐2 in cellular dynamics and in cancerJournal of Cellular Physiology, 2002
- Cyclooxygenase‐2: a possible target in schistosoma‐associated bladder cancerBJU International, 2001